Magnesium-iron layered double hydroxide synthesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing unaged mixed metal compounds, particularly Mg:Fe compounds, face challenges in large-scale manufacturing due to issues like high pressure drops during filtration, low yield, and changes in morphology that affect therapeutic activity, making it difficult to maintain consistent phosphate binding capacity and stability.
Innovation Solution
A method involving the combination of Mg2+ and Fe3+ salts with Na2CO3 and NaOH, maintaining a pH of 9.5 to 11, with excess Na2CO3 from 0 to 4 moles, and subjecting the slurry to mixing under specific power conditions to produce a mixed metal compound with an aluminium content of less than 10000 ppm and an average crystal size of less than 20nm, ensuring controlled drying to maintain key properties.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional methods are used to produce unaged mixed metal compounds, then production can be performed, but high pressure drops during filtration and low yield occur
Solution Approach 1:
The patent applies parameter changes by controlling the pH of the reaction slurry within a specific range (9.5-11) and maintaining excess carbonate ions (0-4 moles of Na2CO3 per mole of divalent metal salt). These parameter adjustments optimize the precipitation process to produce particles with improved filtration characteristics and higher yield, directly resolving the contradiction between productivity and ease of manufacture.
2Manufacturing precision
If mixing is performed without specific power control, then production can proceed, but morphology changes affect therapeutic activity
Solution Approach 1:
The patent specifies precise mixing power parameters (0.03 to 1.6 kW/m³) to control the morphology and crystal size of the mixed metal compound. By changing and controlling this physical parameter, the invention achieves consistent therapeutic activity while managing the complexity of the mixing process through quantifiable specifications.
3Reliability
If drying is performed without controlled conditions, then processing can be completed, but key properties of the compound are compromised
Solution Approach 1:
The patent controls the drying process by limiting the temperature to no greater than 150°C and specifying water evaporation rates (0.05 to 1.5 kg water per hour per kg of dry product). These parameter controls ensure the compound's stability and key properties are maintained while providing clear, manageable manufacturing instructions.
4Reliability
If aluminium-containing compounds are used as phosphate binders, then phosphate binding is achieved, but toxic complications occur due to aluminium accumulation
Solution Approach 1:
The patent extracts and eliminates aluminium from the phosphate binder composition entirely, replacing it with a mixed metal compound comprising magnesium and iron. This removal of the harmful element (aluminium) while maintaining phosphate binding functionality directly resolves the contradiction between therapeutic effectiveness and safety.
Solution Approach 2:
The patent employs a composite mixed metal compound containing magnesium and iron in specific ratios, creating a new material that combines the benefits of both metals for phosphate binding while avoiding the toxicity of aluminium. This composite approach maintains therapeutic effectiveness without the harmful effects.
5Reliability
If calcium-based phosphate binders are used, then phosphate binding is achieved, but hypocalcaemia and cardiovascular calcification occur
Solution Approach 1:
The patent removes calcium from the phosphate binder formulation and replaces it with magnesium and iron-based compounds. This extraction of the harmful element (calcium) while preserving phosphate binding capability directly addresses the contradiction between effectiveness and safety regarding cardiovascular calcification and hypocalcaemia.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enables the production of consistent, stable mixed metal compounds with enhanced phosphate binding capacity and reduced magnesium release, suitable for large-scale pharmaceutical applications, improving tablet formulation and patient compliance.
Implementation Method 1
providing a solution of a water soluble compound of a divalent metal M II comprising at least magnesium and a solution of a water soluble compound of a trivalent metal M III comprising iron and reacting the solutions together under mixing conditions providing a power per unit volume of the slurry of 0.03 to 1.6kW/m 3
Data Source
Figure 1
AI summary
There is provided a method of producing a mixed metal compound comprising at least Mg2+ and at least Fe3+ having an aluminium content of less than 10000 ppm, having an average crystal size of less than 20nm (200A) comprising the steps of: (a) combining a Mg2+ salt and a Fe3+ salt with Na2CO3 and NaOH to produce a slurry, wherein the pH of the slurry is maintained at from 9.5 to 11 , and wherein the Na2CO3 is provided at an excess of 0 to 4.0 moles than is required to complete the reaction (b) subjecting the slurry to mixing under conditions providing a power per unit volume of 0.03 to 1.6kW/m3 (c) separating the mixed metal compound from the slurry, to obtain a crude product having a dry solid content of at least 10 wt% (d) drying the crude product either by (i) heating the crude product to a temperature of no greater than 150°C and sufficient to provide a water evaporation rate of 0.05 to 1.5 kg water per hour per kg of dry product, or (ii) exposing the crude product to rapid drying at a water evaporation rate of 500 to 50000 kg water per hour per kg of dry product.